DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $155.58 million. The enterprise value is $111.58 million.

Market Cap	155.58M
Enterprise Value	111.58M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

DMAC has 42.74 million shares outstanding. The number of shares has increased by 43.51% in one year.

Shares Outstanding	42.74M
Shares Change (YoY)	+43.51%
Shares Change (QoQ)	-0.14%
Owned by Insiders (%)	26.47%
Owned by Institutions (%)	29.29%
Float	23.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.40
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.14, with a Debt / Equity ratio of 0.01.

Current Ratio	18.14
Quick Ratio	17.93
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.20% and return on invested capital (ROIC) is -45.98%.

Return on Equity (ROE)	-36.20%
Return on Assets (ROA)	-34.50%
Return on Capital (ROIC)	-45.98%
Revenue Per Employee	n/a
Profits Per Employee	-$1.01M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMAC has paid $43,000 in taxes.

Income Tax	43,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.89% in the last 52 weeks. The beta is 1.49, so DMAC's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	+13.89%
50-Day Moving Average	2.92
200-Day Moving Average	2.76
Relative Strength Index (RSI)	66.88
Average Volume (20 Days)	67,219

Short Selling Information

The latest short interest is 173,661, so 0.41% of the outstanding shares have been sold short.

Short Interest	173,661
Short Previous Month	156,841
Short % of Shares Out	0.41%
Short % of Float	0.75%
Short Ratio (days to cover)	1.39

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.49M
Pretax Income	-19.23M
Net Income	-19.27M
EBITDA	-19.13M
EBIT	-19.23M
Earnings Per Share (EPS)	-$0.56

Full Income Statement

Balance Sheet

The company has $46.52 million in cash and $380,000 in debt, giving a net cash position of $46.14 million or $1.08 per share.

Cash & Cash Equivalents	46.52M
Total Debt	380,000
Net Cash	46.14M
Net Cash Per Share	$1.08
Equity (Book Value)	46.35M
Book Value Per Share	1.08
Working Capital	44.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.29 million and capital expenditures -$26,000, giving a free cash flow of -$20.32 million.

Operating Cash Flow	-20.29M
Capital Expenditures	-26,000
Free Cash Flow	-20.32M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.51%
Shareholder Yield	-43.51%
Earnings Yield	-12.22%
FCF Yield	-12.88%

Analyst Forecast

The average price target for DMAC is $7.00, which is 92.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	92.31%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 15, 2018
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2